Catalent, Inc. (NYSE:CTLT) Q2 2021 Earnings Conference Call February 2, 2021 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relations John Chiminski - Chairman and CEO Wetteny Joseph - SVP and CFO Conference Call Participants Dan Brennan - UBS John Kreger - William Blair Tycho Peterson - J.P. Morgan Dave Windley - Jefferies Jacob Johnson - Stephens Sean Dodge - RBC Capitals Juan Avendano - Bank of America Jack Meehan - Nephron Research Operator Ladies and gentlemen, thank you for sta ...

Catalent. DEVELOPMENT DELIVERY February 2, 2021 more products. better treatments. reliably supplied." Q2'21 Earnings Call Presentation SUPPLY Agenda John Chiminski, Chair & Chief Executive Officer • Q2'21 review Wetteny Joseph, Senior VP & Chief Financial Officer • Q2'21 business segment financial performance • EBITDA & Adjusted EBITDA • Adjusted Net Income and Adjusted Net Income per Share • Capitalization review • FY'21 financial guidance Question & Answer Session 2 Disclaimer Statement Forward-Looking St ...

Table of Contents Securities registered pursuant to Section 12(b) of the Act: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ______________________________ ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-36587 (Commission File Number) ______________________ ...

| --- | --- | --- | |------------------|-------|-------| | Catalent, Inc. | | | | | | | | | | | | | | | | Investor | | | | | | | | | | | | Presentation | | | | | | | | January 11, 2021 | | | more products. better treatments. reliably supplied." Forward-Looking Statements This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements within the meaning of Section 27A of the Securities A ...

Catalent. Q1'21 Earnings Call Presentation November 3, 2020 DEVELOPMENT DELIVERY SUPPLY more products. better treatments. reliably supplied." Agenda John Chiminski, Chair & Chief Executive Officer • Q1'21 review Wetteny Joseph, Senior VP & Chief Financial Officer • Q1'21 business segment financial performance • EBITDA & Adjusted EBITDA • Adjusted Net Income and Adjusted Net Income per Share • Capitalization review • FY'21 financial guidance Question & Answer Session 2 Disclaimer Statement Forward-Looking St ...

Catalent, Inc. (NYSE:CTLT) Q1 2021 Results Conference Call November 3, 2020 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relations John Chiminski - Chairman and CEO Wetteny Joseph - SVP and CFO Conference Call Participants Dave Windley - Jefferies John Kreger - William Blair Tycho Peterson - J.P. Morgan Juan Avendano - Bank of America Jacob Johnson - Stephens Jack Meehan - Nephron Research Dan Brennan - UBS Thomas Kelliher - RBC Capital Markets Evan Stover - Baird Operator Ladies ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ______________________________ ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-36587 (Commission File Number) _____________________________ Catalent, Inc. (Exact name of registrant as specifi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36587 CATALENT, INC. (Exact name of registrant as specified in its charter) Delaware 20-8737688 (State or other jurisdiction of incorporation or org ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ______________________________ ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-36587 (Commission File Number) _____________________________ Catalent, Inc. (Exact name of registrant as specified i ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ______________________________ ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-36587 (Commission File Number) _____________________________ Catalent, Inc. (Exact name of registrant as specifie ...